 BERKELEY, Calif., Feb. 07, 2022 GLOBE NEWSWIRE -- Caribou Biosciences, Inc. Nasdaq:CRBU, a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today that Rachel Haurwitz, Ph.D., Caribous president and chief executive officer, will participate in a fireside chat at the SVB Leerink 11th Annual Global Healthcare Conference on Thursday, February 17th, at 2:20 pm ET. 